Rewriting the clock: How AI is fast-tracking APAC healthcare and life sciences
AI has strong potential to accelerate antimicrobial resistance research, says Chu Canh Chieu, FPT Software VP & Director of Global Healthcare Center, FPT Corporation.
Independent intelligence on healthtech across Asia and the Middle East
AI has strong potential to accelerate antimicrobial resistance research, says Chu Canh Chieu, FPT Software VP & Director of Global Healthcare Center, FPT Corporation.
Chu Canh Chieu, Managing Director, Global Healthcare Centre at FPT Software, outlines AI's impact on image diagnostics and how it transforms patient outcomes.